Importantly, a high positive CHK1 expression rate (92%) in HCC tumors serves as a potential negative biomarker for HCC correlating with greater T stage, high AFP levels, and worse overall survival. The gene discussed is CHEK1; the disease is hepatocellular carcinoma.